CME Cme Group Inc

Price (delayed)

$184.04

Market cap

$66.07B

P/E Ratio

30.57

Dividend/share

$3.4

EPS

$6.02

Enterprise value

$156.26B

Sector: Financial Services
Industry: Financial Data & Stock Exchanges

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights

The EPS has declined by 9% since the previous quarter but it is up by 6% year-on-year
The company's net income fell by 9% QoQ but it rose by 6% YoY
The debt has surged by 103% year-on-year and by 10% since the previous quarter
CME's P/E is 20% above its 5-year quarterly average of 25.4 and 9% above its last 4 quarters average of 28.0

Key stats

What are the main financial stats of CME
Market
Shares outstanding
358.99M
Market cap
$66.07B
Enterprise value
$156.26B
Valuations
Price to earnings (P/E)
30.57
Price to book (P/B)
2.45
Price to sales (P/S)
13.37
EV/EBIT
52.48
EV/EBITDA
45.45
EV/Sales
31.74
Earnings
Revenue
$4.92B
EBIT
$2.98B
EBITDA
$3.44B
Free cash flow
$2.58B
Per share
EPS
$6.02
Free cash flow per share
$7.21
Book value per share
$75.23
Revenue per share
$13.76
TBVPS
$259.74
Balance sheet
Total assets
$125.76B
Total liabilities
$98.75B
Debt
$91.53B
Equity
$26.98B
Working capital
$1.72B
Liquidity
Debt to equity
3.39
Current ratio
1.02
Quick ratio
1.02
Net debt/EBITDA
26.24
Margins
EBITDA margin
69.8%
Gross margin
100%
Net margin
43.7%
Operating margin
54.7%
Efficiency
Return on assets
1.9%
Return on equity
8.1%
Return on invested capital
3.6%
Return on capital employed
8%
Return on sales
60.5%
Dividend
Dividend yield
1.85%
DPS
$3.4
Payout ratio
56.5%

CME stock price

How has the Cme Group stock price performed over time
Intraday
-1.16%
1 week
-4.06%
1 month
1.68%
1 year
-11.3%
YTD
1.09%
QTD
1.09%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$4.92B
Gross profit
$4.92B
Operating income
$2.7B
Net income
$2.15B
Gross margin
100%
Net margin
43.7%
The company's net income fell by 9% QoQ but it rose by 6% YoY
The net margin has grown by 7% year-on-year but it has declined by 6% since the previous quarter
The operating income is down by 6% QoQ
The gross profit has decreased by 3.8% from the previous quarter

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
P/E
30.57
P/B
2.45
P/S
13.37
EV/EBIT
52.48
EV/EBITDA
45.45
EV/Sales
31.74
CME's P/E is 20% above its 5-year quarterly average of 25.4 and 9% above its last 4 quarters average of 28.0
The EPS has declined by 9% since the previous quarter but it is up by 6% year-on-year
CME's price to book (P/B) is 11% higher than its 5-year quarterly average of 2.2 and 2.1% higher than its last 4 quarters average of 2.4
The P/S is 7% higher than the last 4 quarters average of 12.5 and 5% higher than the 5-year quarterly average of 12.7
CME's revenue is down by 3.8% since the previous quarter

Efficiency

How efficient is Cme Group business performance
The ROIC has contracted by 46% YoY and by 20% from the previous quarter
Cme Group's return on assets has decreased by 30% YoY and by 17% QoQ
Cme Group's return on equity has decreased by 9% QoQ but it has increased by 5% YoY
The return on sales is up by 2.9% year-on-year but it has declined by 2.1% since the previous quarter

Dividends

What is CME's dividend history
DPS
$3.4
Dividend yield
1.85%
Payout ratio
56.5%
Recent dividends

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 27% more than its total liabilities
Cme Group's total liabilities has surged by 88% YoY and by 9% QoQ
Cme Group's total assets has soared by 58% YoY and by 7% from the previous quarter
The debt has surged by 103% year-on-year and by 10% since the previous quarter
The debt to equity has soared by 102% YoY and by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.